US Patent Issued to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) on June 16 for "Fused ring compound as Wee-1 inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,655,127, issued on June 16, was assigned to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) Co. LTD. (Shanhai, China).

"Fused ring compound as Wee-1 inhibitor" was invented by Yuli Xie (Shanghai), Yingming Wu (Shanghai), Houxing Fan (Shanghai) and Lihui Qian (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses a fused cyclic compound as a Wee-1 inhibitor. Specifically, the present invention relates to a compound of general formula (1), a method for preparing same, and use of the compound of general formula (1) or an isomer, a crystalline form, a pharmaceutically acceptable salt, a hydrate or a solvate thereof as a Wee-1 inhib...